Brandon C Rosen

University Of Miami School Of Medicine

$198,932

Attributed

$198,932

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $51K · FY2019–22

$100K$75K$50K$25K$0

'19

'20

'21

'22

Funding mix

By agency

NIH$198,932 · 1

By mechanism

F30$198,932 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Miami School Of Medicine

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Acquired Immunodeficiency Syndrome”

Kimberly Smith · Ppd Development Lp$122,008,792
Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
Leonard Freedman · Leidos Biomedical Research, Inc.$67,132,816
Bambra Strokes · Ppd Development Lp$65,000,267
Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909

Research focus

Acquired Immunodeficiency SyndromeAdaptive Immune SystemAdaptive ImmunityAcute InfectionAids/Hiv ProblemAnimalsAntibodiesAntigensAffinityAnti-Retroviral AgentsAntiretroviral TherapyAntiviral ImmunityAutologousBaseBindingBiotechnologyCcr5 GeneCd4 Positive T LymphocytesAnti-IggCellsCell SurfaceChimeric ProteinsChronic InfectionCoculture Techniques

Grant awards (4)

Retargeting cytotoxic T lymphocytes in HIV/SIV infection to kill infected cells$47,360

F30 · FY2022 · AI · contact PI

Retargeting cytotoxic T lymphocytes in HIV/SIV infection to kill infected cells$51,036

F30 · FY2021 · AI · contact PI

Retargeting cytotoxic T lymphocytes in HIV/SIV infection to kill infected cells$50,520

F30 · FY2020 · AI · contact PI

Retargeting cytotoxic T lymphocytes in HIV/SIV infection to kill infected cells$50,016

F30 · FY2019 · AI · contact PI